GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.06.24	Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients with primary advanced or recurrent endometrial cancer (EN, GlaxoSmithKline)
08.06.24	US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk (Businesswire)
07.03.24	GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise (Businesswire)
06.02.24	GSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk (Businesswire)
12.12.23	GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity (Businesswire)
13.11.23	GSK and Queer Eye’s Thom Filicia Partner on Blood Cancer Awareness Initiative (Businesswire)
25.10.23	New Data for AREXVY, GSK’s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease (Businesswire)
05.09.23	GSK and Earvin "Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations (Businesswire)
17.08.23	GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies (Businesswire)
31.07.23	Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer (Businesswire)
13.07.23	GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US (Businesswire)
21.06.23	GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons (Businesswire)
20.06.23	GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to "Ask2BSure” about Meningitis B (Businesswire)
01.06.23	GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US (Businesswire)
03.05.23	US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults (Businesswire)
14.03.23	GSK and Earvin "Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older Adults (Businesswire)
11.12.22	New data at ASH underscore the potential for durable, clinically important responses with momelotinib for myelofibrosis patients (Businesswire)
11.07.22	GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses (Businesswire)
29.06.22	GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community (Businesswire)
14.03.20	Coronavirus: Diese Medizinkonzerne forschen an einem Gegenmittel (finanzen.ch) Um das Coronavirus bekämpfen zu können, arbeiten mehr und mehr Unternehmen an der Entwicklung von Impfstoffen oder einer Behandlung gegen COVID-19. Die Forschung läuft auf Hochtouren. Das ist der aktuelle Status.» mehr
28.07.19	Pfizer und Mylan erwägen Fusion bei patentfreiem Arzneimittelgeschäft (Dow Jones) Pfizer ist derzeit in Fusionsgesprächen mit dem Generikahersteller Mylan NV für sein patentfreies Arzneimittelgeschäft, sagten mehrere mit der Angelegenheit vertraute Personen.» mehr
04.05.19	UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S (Reuters)
07.08.18	GlaxoSmithKline appoints HSBC's Iain Mackay as new CFO (Reuters)
07.08.18	GlaxoSmithKline appoints Iain Mackay as CFO (Reuters)
21.07.18	GlaxoSmithKline considers splitting up the group - FT (Reuters)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Holcim	58.54	1.00 %	K V
Alcon	70.42	0.95 %	K V
Swiss Re	137.50	0.88 %	K V
Logitech Intl	71.00	0.40 %	K V
UBS Group	25.85	0.31 %	K V
Swisscom	559.00	-1.67 %	K V
Givaudan	3’914.00	-1.90 %	K V
Sika	215.80	-1.95 %	K V
Nestle	79.73	-2.74 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

GlaxoSmithKline Aktie VALOR 1004120 / ISIN ARDEUT110483

Nachrichten zu GlaxoSmithKline PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

Aktien Top/Flop

Meistgelesene Nachrichten